
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $53.7M | -- | -- | $0.40 | -- |
08/07/2025 | Q2 | $53.4M | -- | -- | $0.40 | -- |
05/07/2025 | Q1 | $53.4M | $22.1M | $0.37 | $0.41 | -$0.04 |
02/25/2025 | Q4 | $57.1M | $24.5M | $0.42 | $0.43 | -$0.01 |
11/06/2024 | Q3 | $58M | $24.6M | $0.40 | $0.43 | -$0.03 |
08/07/2024 | Q2 | $58.1M | $25.8M | $0.43 | $0.43 | $0.00 |
05/09/2024 | Q1 | $58.4M | $30.1M | $0.51 | $0.43 | $0.08 |
02/27/2024 | Q4 | $59.7M | $26M | $0.43 | $0.43 | -$0.00 |
11/07/2023 | Q3 | -- | -- | $0.49 | $0.43 | $0.06 |
08/08/2023 | Q2 | -- | -- | $0.35 | $0.42 | -$0.07 |
05/10/2023 | Q1 | -- | -- | $0.13 | $0.42 | -$0.29 |
02/28/2023 | Q4 | -- | -- | $0.36 | $0.40 | -$0.04 |
11/02/2022 | Q3 | -- | -- | $0.25 | $0.38 | -$0.13 |
08/02/2022 | Q2 | -- | -- | -$0.29 | $0.35 | -$0.64 |
05/03/2022 | Q1 | -- | -- | $0.04 | $0.36 | -$0.32 |
03/01/2022 | Q4 | -- | -- | $0.15 | $0.38 | -$0.23 |
11/03/2021 | Q3 | -- | -- | $0.32 | $0.37 | -$0.05 |
08/03/2021 | Q2 | -- | -- | $0.44 | $0.37 | $0.07 |
05/05/2021 | Q1 | -- | -- | $0.51 | $0.36 | $0.15 |
02/24/2021 | Q4 | -- | -- | $0.43 | $0.35 | $0.08 |
11/05/2020 | Q3 | -- | -- | $0.44 | $0.35 | $0.09 |
08/04/2020 | Q2 | -- | -- | $1.28 | $0.35 | $0.93 |
05/07/2020 | Q1 | -- | -- | -$1.79 | $0.42 | -$2.21 |
02/20/2020 | Q4 | -- | -- | -$0.05 | $0.44 | -$0.49 |
11/04/2019 | Q3 | -- | -- | $0.32 | $0.44 | -$0.12 |
08/05/2019 | Q2 | -- | -- | $0.44 | $0.44 | -$0.00 |
05/06/2019 | Q1 | -- | -- | $0.44 | $0.44 | -$0.00 |
02/21/2019 | Q4 | -- | -- | $0.43 | $0.43 | -$0.00 |
11/05/2018 | Q3 | -- | -- | $0.44 | $0.45 | -$0.01 |
08/06/2018 | Q2 | -- | -- | $0.45 | $0.46 | -$0.01 |
05/07/2018 | Q1 | -- | -- | $0.45 | $0.45 | -$0.00 |
02/22/2018 | Q4 | -- | -- | $0.44 | $0.43 | $0.01 |
11/02/2017 | Q3 | -- | -- | $0.41 | $0.42 | -$0.01 |
08/01/2017 | Q2 | -- | -- | $0.38 | $0.41 | -$0.03 |
05/03/2017 | Q1 | -- | -- | $0.39 | $0.43 | -$0.04 |
02/22/2017 | Q4 | -- | -- | $0.42 | $0.43 | -$0.01 |
11/02/2016 | Q3 | -- | -- | $0.40 | $0.43 | -$0.03 |
08/03/2016 | Q2 | -- | -- | $0.46 | $0.41 | $0.05 |
05/03/2016 | Q1 | -- | -- | $0.40 | $0.41 | -$0.01 |
02/24/2016 | Q4 | -- | -- | $0.40 | $0.40 | -- |
11/03/2015 | Q3 | -- | -- | $0.40 | $0.39 | $0.01 |
SLR Investment reported $22.1M worth of top line sales in its most recent quarter.
SLR Investment announced earnings per share of $0.37 which represents a miss of analyst forecast a $0.41 per share.
SLR Investment reported -- that represents -- per share over the last quarter.
SLR Investment's earnings are forecast to decrease from $1.76 per share to $1.76 per share next year representing a decrease of -7.35%.
SLR Investment's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.